Instruction for use: Vaccine typhoid

Trade name of the drug – Vianvac, Typhivac, Typhim Vi

The Latin name of the substance Vaccine typhoid

Vaccinum ad prophylaxim typhi abdominalis (genus. Vaccini ad prophylaxim typhi abdominalis)

Pharmacological group:

Vaccines, serums, phages and toxoids

Model clinical-pharmacological article 1

Pharmacotherapy. Polysaccharide vaccine for the prevention of typhoid fever, created on the basis of components (capsular antigen) of the pathogen, forms active specific immunity to the Salmonella typhi bacteria. Specific immunity develops in 2-3 weeks after a single injection and persists for at least 3 years.

Indication. Typhoid fever (prophylaxis) in adults and children older than 5 years (in particular for people going to endemic regions, medical personnel and the military).

Contraindications. Hypersensitivity to vaccine components (history); Hyperthermia or infectious disease (it is recommended to postpone vaccination), children's age (up to 5 years), pregnancy (if necessary, a consultation with a specialist doctor of the appropriate profile is recommended).

Dosing. SC or IM, a single injection of 0.5 ml. Revaccination in 3 years.

Side effect. Slight soreness at the injection site (within 24 hours after vaccination), rarely - flushing or condensation at the injection site, hyperthermia (in 1-5% of cases).

Special instructions. Children under 2 years of age are not recommended for vaccination (young children are very rarely sick with typhoid fever). To resolve the issue of vaccination of children from 2 to 5 years, it is necessary to consult a specialist doctor.